Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Oct 15;100(8):1941–1950. doi: 10.1172/JCI119725

Hypercalcemia stimulates expression of intrarenal phospholipase A2 and prostaglandin H synthase-2 in rats. Role of angiotensin II AT1 receptors.

H Mangat 1, L N Peterson 1, K D Burns 1
PMCID: PMC508383  PMID: 9329957

Abstract

In chronic hypercalcemia, inhibition of thick ascending limb sodium chloride reabsorption is mediated by elevated intrarenal PGE2. The mechanisms and source of elevated PGE2 in hypercalcemia are not known. We determined the effect of hypercalcemia on intrarenal expression of cytosolic phospholipase A2 (cPLA2), prostaglandin H synthase-1 (PGHS-1), and prostaglandin H synthase-2 (PGHS-2), enzymes important in prostaglandin production. In rats fed dihydrotachysterol to induce hypercalcemia, Western blot analysis revealed significant upregulation of both cPLA2 and PGHS-2 in the kidney cortex and the inner and outer medulla. Immunofluorescence localized intrarenal cPLA2 and PGHS-2 to interstitial cells of the inner and outer medulla, and to macula densa and cortical thick ascending limbs in both control and hypercalcemic rats. Hypercalcemia had no effect on intrarenal expression of PGHS-1. To determine if AT1 angiotensin II receptor activation was involved in the stimulation of cPLA2 and PGHS-2 in hypercalcemia, we treated rats with the AT1 receptor antagonist, losartan. Losartan abolished the polydipsia associated with hypercalcemia, prevented the increase in cPLA2 protein in all regions of the kidney, and diminished PGHS-2 expression in the inner medulla. In addition, losartan completely prevented the increase in urinary PGE2 excretion in hypercalcemic rats. Intrarenal levels of angiotensin II were unchanged in hypercalcemia. These data indicate that hypercalcemia stimulates intrarenal cPLA2 and PGHS-2 protein expression. Our results further support a role for angiotensin II, acting on AT1 receptors, in mediating this stimulation.

Full Text

The Full Text of this article is available as a PDF (740.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachmann S., Bosse H. M., Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol. 1995 May;268(5 Pt 2):F885–F898. doi: 10.1152/ajprenal.1995.268.5.F885. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Brown C. A., Zusman R. M., Haber E. Identification of an angiotensin receptor in rabbit renomedullary interstitial cells in tissue culture. Correlation with prostaglandin biosynthesis. Circ Res. 1980 Jun;46(6):802–807. doi: 10.1161/01.res.46.6.802. [DOI] [PubMed] [Google Scholar]
  4. COHEN S. I., FITZGERALD M. G., FOURMAN P., GRIFFITHS W. J., DE WARDENER H. E. Polyuria in hyperparathyroidism. Q J Med. 1957 Oct;26(104):423–431. [PubMed] [Google Scholar]
  5. DeWitt D. L., Meade E. A. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch Biochem Biophys. 1993 Oct;306(1):94–102. doi: 10.1006/abbi.1993.1485. [DOI] [PubMed] [Google Scholar]
  6. Douglas J. G., Hopfer U. Novel aspect of angiotensin receptors and signal transduction in the kidney. Annu Rev Physiol. 1994;56:649–669. doi: 10.1146/annurev.ph.56.030194.003245. [DOI] [PubMed] [Google Scholar]
  7. EPSTEIN F. H., BECK D., CARONE F. A., LEVITIN H., MANITIUS A. Changes in renal concentrating ability produced by parathyroid extract. J Clin Invest. 1959 Jul;38(7):1214–1221. doi: 10.1172/JCI103896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. EPSTEIN F. H., RIVERA M. J., CARONE F. A. The effect of hypercalcemia induced by calciferol upon renal concentrating ability. J Clin Invest. 1958 Dec;37(12):1702–1709. doi: 10.1172/JCI103762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Farman N., Pradelles P., Bonvalet J. P. Determination of prostaglandin E2 synthesis along rabbit nephron by enzyme immunoassay. Am J Physiol. 1986 Aug;251(2 Pt 2):F238–F244. doi: 10.1152/ajprenal.1986.251.2.F238. [DOI] [PubMed] [Google Scholar]
  10. Farman N., Pradelles P., Bonvalet J. P. PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and TxB2 synthesis along the rabbit nephron. Am J Physiol. 1987 Jan;252(1 Pt 2):F53–F59. doi: 10.1152/ajprenal.1987.252.1.F53. [DOI] [PubMed] [Google Scholar]
  11. GILL J. R., Jr, BARTTER F. C. On the impairment of renal concentrating ability in prolonged hypercalcemia and hypercalciuria in man. J Clin Invest. 1961 Apr;40:716–722. doi: 10.1172/JCI104305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gronich J. H., Bonventre J. V., Nemenoff R. A. Purification of a high-molecular-mass form of phospholipase A2 from rat kidney activated at physiological calcium concentrations. Biochem J. 1990 Oct 1;271(1):37–43. doi: 10.1042/bj2710037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Habib A., Créminon C., Frobert Y., Grassi J., Pradelles P., Maclouf J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem. 1993 Nov 5;268(31):23448–23454. [PubMed] [Google Scholar]
  14. Harris R. C., McKanna J. A., Akai Y., Jacobson H. R., Dubois R. N., Breyer M. D. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994 Dec;94(6):2504–2510. doi: 10.1172/JCI117620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kaji D. M., Chase H. S., Jr, Eng J. P., Diaz J. Prostaglandin E2 inhibits Na-K-2Cl cotransport in medullary thick ascending limb cells. Am J Physiol. 1996 Jul;271(1 Pt 1):C354–C361. doi: 10.1152/ajpcell.1996.271.1.C354. [DOI] [PubMed] [Google Scholar]
  16. Kester M., Coroneos E., Thomas P. J., Dunn M. J. Endothelin stimulates prostaglandin endoperoxide synthase-2 mRNA expression and protein synthesis through a tyrosine kinase-signaling pathway in rat mesangial cells. J Biol Chem. 1994 Sep 9;269(36):22574–22580. [PubMed] [Google Scholar]
  17. Kline R. L., Liu F. Modification of pressure natriuresis by long-term losartan in spontaneously hypertensive rats. Hypertension. 1994 Oct;24(4):467–473. doi: 10.1161/01.hyp.24.4.467. [DOI] [PubMed] [Google Scholar]
  18. Kraly F. S., Corneilson R. Angiotensin II mediates drinking elicited by eating in the rat. Am J Physiol. 1990 Feb;258(2 Pt 2):R436–R442. doi: 10.1152/ajpregu.1990.258.2.R436. [DOI] [PubMed] [Google Scholar]
  19. Kujubu D. A., Fletcher B. S., Varnum B. C., Lim R. W., Herschman H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 1991 Jul 15;266(20):12866–12872. [PubMed] [Google Scholar]
  20. Kujubu D. A., Reddy S. T., Fletcher B. S., Herschman H. R. Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. J Biol Chem. 1993 Mar 15;268(8):5425–5430. [PubMed] [Google Scholar]
  21. Langenbach R., Morham S. G., Tiano H. F., Loftin C. D., Ghanayem B. I., Chulada P. C., Mahler J. F., Lee C. A., Goulding E. H., Kluckman K. D. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 1995 Nov 3;83(3):483–492. doi: 10.1016/0092-8674(95)90126-4. [DOI] [PubMed] [Google Scholar]
  22. Lee S. H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D., Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992 Dec 25;267(36):25934–25938. [PubMed] [Google Scholar]
  23. Levi M., Peterson L., Berl T. Mechanism of concentrating defect in hypercalcemia. Role of polydipsia and prostaglandins. Kidney Int. 1983 Mar;23(3):489–497. doi: 10.1038/ki.1983.46. [DOI] [PubMed] [Google Scholar]
  24. Liu L., Ng M., Iacopino A. M., Dunn S. T., Hughes M. R., Bourdeau J. E. Vitamin D receptor gene expression in mammalian kidney. J Am Soc Nephrol. 1994 Nov;5(5):1251–1258. doi: 10.1681/ASN.V551251. [DOI] [PubMed] [Google Scholar]
  25. Mitchell J. A., Larkin S., Williams T. J. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol. 1995 Nov 9;50(10):1535–1542. doi: 10.1016/0006-2952(95)00212-x. [DOI] [PubMed] [Google Scholar]
  26. Mujais S. K., Kauffman S., Katz A. I. Angiotensin II binding sites in individual segments of the rat nephron. J Clin Invest. 1986 Jan;77(1):315–318. doi: 10.1172/JCI112293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mukherjee A. B., Miele L., Pattabiraman N. Phospholipase A2 enzymes: regulation and physiological role. Biochem Pharmacol. 1994 Jul 5;48(1):1–10. doi: 10.1016/0006-2952(94)90216-x. [DOI] [PubMed] [Google Scholar]
  28. O'Banion M. K., Winn V. D., Young D. A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4888–4892. doi: 10.1073/pnas.89.11.4888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Peterson L. N., McKay A. J., Borzecki J. S. Endogenous prostaglandin E2 mediates inhibition of rat thick ascending limb Cl reabsorption in chronic hypercalcemia. J Clin Invest. 1993 Jun;91(6):2399–2407. doi: 10.1172/JCI116473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Peterson L. N. Vitamin D-induced chronic hypercalcemia inhibits thick ascending limb NaCl reabsorption in vivo. Am J Physiol. 1990 Jul;259(1 Pt 2):F122–F129. doi: 10.1152/ajprenal.1990.259.1.F122. [DOI] [PubMed] [Google Scholar]
  31. Pitcock J. A. Morphometric studies of the renomedullary interstitial cells. Am J Med Sci. 1988 Apr;295(4):246–251. doi: 10.1097/00000441-198804000-00005. [DOI] [PubMed] [Google Scholar]
  32. Rao G. N., Lassègue B., Alexander R. W., Griendling K. K. Angiotensin II stimulates phosphorylation of high-molecular-mass cytosolic phospholipase A2 in vascular smooth-muscle cells. Biochem J. 1994 Apr 1;299(Pt 1):197–201. doi: 10.1042/bj2990197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ruzicka M., Skarda V., Leenen F. H. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Circulation. 1995 Dec 15;92(12):3568–3573. doi: 10.1161/01.cir.92.12.3568. [DOI] [PubMed] [Google Scholar]
  34. Schramek H., Wang Y., Konieczkowski M., Simonson M. S., Dunn M. J. Endothelin-1 stimulates cytosolic phospholipase A2 activity and gene expression in rat glomerular mesangial cells. Kidney Int. 1994 Dec;46(6):1644–1652. doi: 10.1038/ki.1994.464. [DOI] [PubMed] [Google Scholar]
  35. Serros E. R., Kirschenbaum M. A. Prostaglandin-dependent polyuria in hypercalcemia. Am J Physiol. 1981 Sep;241(3):F224–F230. doi: 10.1152/ajprenal.1981.241.3.F224. [DOI] [PubMed] [Google Scholar]
  36. Siragy H. M., Carey R. M. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest. 1996 Apr 15;97(8):1978–1982. doi: 10.1172/JCI118630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Smith W. L., Bell T. G. Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. Am J Physiol. 1978 Nov;235(5):F451–F457. doi: 10.1152/ajprenal.1978.235.5.F451. [DOI] [PubMed] [Google Scholar]
  38. Smith W. L., DeWitt D. L. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol. 1995 May;15(3):179–194. [PubMed] [Google Scholar]
  39. Taverner D., Bing R. F., Fletcher A., Russell G., Swales J. D., Thurston H. Hypertension produced by chemical renal medullectomy: evidence for a renomedullary vasodepressor function in the rat. Clin Sci (Lond) 1984 Nov;67(5):521–528. doi: 10.1042/cs0670521. [DOI] [PubMed] [Google Scholar]
  40. Terada Y., Tomita K., Nonoguchi H., Marumo F. PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int. 1993 Jun;43(6):1251–1259. doi: 10.1038/ki.1993.177. [DOI] [PubMed] [Google Scholar]
  41. Wu K. K. Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles. J Lab Clin Med. 1996 Sep;128(3):242–245. doi: 10.1016/s0022-2143(96)90023-2. [DOI] [PubMed] [Google Scholar]
  42. Yosipiv I. V., el-Dahr S. S. Activation of angiotensin-generating systems in the developing rat kidney. Hypertension. 1996 Feb;27(2):281–286. doi: 10.1161/01.hyp.27.2.281. [DOI] [PubMed] [Google Scholar]
  43. Zhuo J., Alcorn D., McCausland J., Mendelsohn F. A. Localization and regulation of angiotensin II receptors in renomedullary interstitial cells. Kidney Int. 1994 Dec;46(6):1483–1485. doi: 10.1038/ki.1994.425. [DOI] [PubMed] [Google Scholar]
  44. Zusman R. M., Keiser H. R. Regulation of prostaglandin E2 synthesis by angiotensin II, potassium, osmolality, and dexamethasone. Kidney Int. 1980 Mar;17(3):277–283. doi: 10.1038/ki.1980.33. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES